Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Dec 2016
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 12 Dec 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Feb 2017.
- 12 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 04 Nov 2015 New trial record